Linkage to Health, Inc. was founded in December 2015 by Executive Director, Wayne Gosbee. The rationale that led to the forming of Linkage to Health was that currently still too many barriers loom for Hep C, HIV, and other chronic disease individuals trying to access care and that sometimes all it takes a little more hand holding to “link” people into care that don’t know where to start.
The Linkage to Health Executive Director brings his eight years of experience from CHI St. Luke’s Health and Vertex Pharmaceuticals to this organization. Mr. Gosbee served as the Liver Health Outreach Coordinator during his tenure at St. Luke’s and as the HCV Public Health Manager for six states in the South Region while with Vertex. During these years, Mr. Gosbee increased testing for HCV at health fairs by adding cholesterol, a non-stigmatizing test, then moved to partnering with other organizations such as HIV/STD clinics. Through these efforts, over 15,000 individuals were tested for HCV since 2007. Mr. Gosbee conducts approximately 25 presentations per year on Hepatitis C, including information on transmission, testing, linkage to care and treatment, made several TV and radio appearances, and was on a panel of experts for Medscape on “Best Practices in HCV Screening and Linkage to Care.” He has co-organized the Texas Viral Hepatitis Summit since 2009 and has been recognized for his work in HCV twice: In November 2013 he received a Certificate of Recognition from the Texas Department of State Health Services for viral hepatitis services to Texas Communities and in May 2015 received recognition from state Representative Sarah Davis at the Capitol in Austin for his accomplishments in the HCV field. Thus, although the current organization has just come into being, its Executive Director and the Board of Directors have over 70 years’ experience, and all are recognized as experts in the Hepatitis C field. He brings with him vast knowledge, expertise and a passion for Hepatitis C prevention and treatment as well as expertise in testing in the various communities and establishing some form of linkages to treat HCV individuals.